CELYAD ONCOLOGY (CYAD.BR) Stock Analyst Ratings
EBR:CYAD - Euronext Brussels - BE0974260896 - Common Stock - Currency: EUR
ChartMill assigns a Buy % Consensus number of 42% to CYAD.BR. The Buy consensus is the weighted average rating of the current analysts ratings.
CYAD.BR was analyzed by 9 analysts. The buy percentage consensus is at 42. So analysts seem to be rather negative about CYAD.BR.
In the previous month the buy percentage consensus was at a similar level.
CYAD.BR was analyzed by 9 analysts. More opinions would make the average more meaningful.